Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

NCT01560260 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Carney Complex
Chondrosarcoma
Gastrointestinal Stromal Tumor
Paraganglioma

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Linsitinib
OTHER: Pharmacological Study

Sponsor

National Cancer Institute (NCI)